Clinical Trial Update: Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating interstitial photodynamic therapy for recurrent head and neck cancer was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Laryngeal Cancer
• Oral Cavity Cancer
• Oropharyngeal Cancer
• Tongue Cancer
• Verrucous Carcinoma of Head and Neck

Drugs mentioned

• Photofrin (porfimer sodium)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2017-08-28